Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Erratum: Vol. 50, No. 20
In the Notice to Readers, "Deferral of Routine Booster Doses of Tetanus
and Diphtheria Toxoids for Adolescents and Adults," three errors occurred. The
second sentence of the first paragraph should read "Aventis Pasteur
(Swiftwater, Pennsylvania) is the only major manufacturer of tetanus and diphtheria toxoids (Td)
in the United States." The last sentence of the second paragraph should read "Td
use should follow existing recommendations for all other indications, which include
1) persons traveling to a country where the risk for diphtheria is high*; 2)
persons requiring tetanus vaccination for prophylaxis in wound management; 3) persons
who have received <3 doses of any vaccine containing tetanus and diphtheria toxoids;
and 4) pregnant women who have not been vaccinated with Td during the preceding
10 years." The fourth sentence in the fourth paragraph should read "For persons with
>3 doses of tetanus toxoid-containing vaccine and severe or contaminated wounds,
Td should be given only if >5 years have passed since the last dose of tetanus
toxoid-containing vaccine."
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
